- Home
- BE vs HOLX Comparison
BE vs HOLX Comparison
Compare BE & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BE | HOLX |
|---|---|---|
| Founded | 2001 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 16.6B |
| IPO Year | 2018 | 1990 |
Fundamental Metrics
Financial Performance| Metric | BE | HOLX |
|---|---|---|
| Price | $90.16 | $74.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $83.16 | $79.10 |
| AVG Volume (30 Days) | ★ 11.7M | 2.8M |
| Earning Date | 10-28-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.07 | ★ 2.49 |
| Revenue | $1,818,704,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $31.70 | $6.72 |
| Revenue Next Year | $29.83 | $5.48 |
| P/E Ratio | $1,396.85 | ★ $29.92 |
| Revenue Growth | ★ 44.53 | 1.74 |
| 52 Week Low | $15.15 | $51.90 |
| 52 Week High | $147.86 | $75.34 |
Technical Indicators
Market Signals| Indicator | BE | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 49.09 |
| Support Level | $88.66 | $74.19 |
| Resistance Level | $96.49 | $75.03 |
| Average True Range (ATR) | 8.10 | 0.22 |
| MACD | -0.41 | -0.15 |
| Stochastic Oscillator | 32.45 | 26.52 |
Price Performance
Historical ComparisonAbout BE Bloom Energy Corporation
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. Bloom primarily sells its systems in the United States and internationally.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.